Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stroke: therapeutic approaches.

J Gilmore1, R Horton

  • 1Eli Lilly and Co. Ltd., Lilly Research Centre, Erl Wood Manor, Windlesham, Surrey, UK.

Drug News & Perspectives
|December 24, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for Light Pseudoscalar Bosons, Pair-Produced in Higgs Boson Decays in the Four-Electron Final State in Proton-Proton Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

First Evidence for Mixing-Induced CP Violation in B_{s}^{0}→J/ψϕ(1020) Decays in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2026
Same author

Observation of Suppressed Charged-Particle Production in Ultrarelativistic Oxygen-Oxygen Collisions.

Physical review letters·2026
Same author

Measurement of D^{0} Meson Photoproduction in Ultraperipheral Heavy Ion Collisions.

Physical review letters·2026
Same author

Observation of tWZ Production at the CMS Experiment.

Physical review letters·2026
Same author

First Exclusive Reconstruction of the B^{*+}, B^{*0}, and B_{s}^{*0} Mesons and Precise Measurement of Their Masses.

Physical review letters·2026
Same journal

New drug discovery and development in India.

Drug news & perspectives·2013
Same journal

Are we living in the end of the blockbuster drug era?

Drug news & perspectives·2010
Same journal

Molecule of the Month. TAK-875.

Drug news & perspectives·2010
Same journal

Epigenetic alterations of tumor marker microRNAs: towards new cancer therapies.

Drug news & perspectives·2010
Same journal

Electroporation: a promising method for the nonviral delivery of DNA vaccines in humans?

Drug news & perspectives·2010
Same journal

Trioxaquines: hybrid molecules for the treatment of malaria.

Drug news & perspectives·2010
See all related articles

Drug development for stroke faces challenges, particularly in late-stage trials. Careful examination of side effect profiles, pharmacokinetics, and distribution is crucial to minimize cardiovascular risks.

Area of Science:

  • Neurology
  • Pharmacology
  • Clinical Trials

Background:

  • Stroke remains a leading cause of disability and death.
  • Many promising stroke therapies fail during late-stage clinical trials.
  • Understanding reasons for drug failure is critical for advancing stroke treatment.

Purpose of the Study:

  • To review challenges in stroke drug development.
  • To discuss in vitro and in vivo models of ischemia.
  • To explore therapeutic approaches for stroke.

Main Methods:

  • Symposium presentation and discussion.
  • Review of late-stage clinical trial failures.
  • Analysis of ischemia models.
  • Evaluation of therapeutic strategies.

Related Experiment Videos

Main Results:

  • Drug development failures are multifactorial.
  • In vitro and in vivo models aid research but have limitations.
  • Cardiovascular side effects are a significant concern in stroke drug trials.

Conclusions:

  • Thorough evaluation of side effect profiles is essential.
  • Pharmacokinetics and drug distribution require close examination.
  • Minimizing cardiovascular effects is key to successful stroke drug development.